The Third People's Hospital of Hangzhou
11
3
3
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Westlake Aging Cohort (WeAC)
Role: collaborator
Electroacupuncture for PHN: Efficacy and Biomarker Evaluation in a Multicenter, Randomized, Sham-Controlled Trial Protocol
Role: collaborator
The PRECISION-T2D Study: Precision Nutrition Study for Type 2 Diabetes
Role: collaborator
Interleukin-2 for Refractory Chronic Spontaneous Urticaria
Role: collaborator
Efficacy of Electroacupuncture Combined With Pregabalin in the Treatment of Trigeminal Herpetic Neuralgia: a Multicenter Randomized Controlled Trial Study Protocol
Role: lead
Evaluation of Tp-e Interval and Tp-e/QT Ratio in Dermatomyositis and Analysis of Their Relationship With Inflammation
Role: lead
Tranilast Vs. Steroids to Prevent Esophageal Stricture (TAPES) After Endoscopic Resection for Superficial Neoplasms
Role: collaborator
Cross-sectional Survey of Zhejiang ECMO Application
Role: collaborator
An Investigation on the Role of Emergency Departments in Combatting Against COVID-19 in Zhejiang Province
Role: collaborator
Investigation on the Practice Status of Emergency Stuff
Role: collaborator
Anlotinib Hydrochloride For Advanced Soft Tissue Sarcoma Patients Who Do Not Receive Chemotherapy
Role: collaborator
All 11 trials loaded